Archive · 15 Sep 2025
New Gene Therapy Shows Promise for Genetic Hearing Loss
Scientists have created a new treatment for hearing loss caused by genetics.
This new treatment is a gene therapy, using a harmless virus to deliver a healthy copy of a specific gene.
This gene therapy is more efficient than existing approaches, and could help people with hearing problems.
The therapy targets a gene called CLIC5, which is important for hearing and balance.
The therapy prevents the tiny hairs in your ear from being damaged, so you can hear and keep your balance.
This approach may lead to therapies for other genetic conditions, too.
A new gene therapy is showing promise for treating genetic hearing loss.
The therapy aims to prevent the degeneration of sensory cells in the ear.
The research was led by scientists from Israel and the US.
The therapy targets the CLIC5 gene using a viral vector.
The therapy could pave the way for treating other inherited disorders.
- Who
- Israeli and US scientists
- What
- Developed a gene therapy to treat genetic hearing loss.
- When
- The research findings were featured in the journal EMBO Molecular Medicine.
- Where
- Conducted at Tel Aviv University and Boston Children's Hospital
- Why
- To potentially cure genetic hearing loss, which affects millions globally.
- Main focus
- New gene therapy to treat genetic hearing loss
- Key feature
- Prevents sensory cell degeneration in the ear
- Target
- CLIC5 gene
- Research Lead
- Professor Karen Avraham, Tel Aviv University
- Mechanism
- Viral vector delivers healthy gene copy
- Potential Applications
- Other inherited hearing disorders, and neurological disorders